Back
Protagonist Therapeutics Vs. Dave Industry Stock Comparison
Sell
29
PTGX
Protagonist Therapeutics
Last Price:
41.02
Seasonality Move:
12.96%
Buy
99
DAVE
Dave
Last Price:
79.94
Seasonality Move:
82.07%
Sell
29
Protagonist Therapeutics (PTGX)
is a Sell
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $41.04. The Score for PTGX is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- PTGX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
99
Dave (DAVE)
is a Buy
Is Dave a Buy, Sell or Hold?
- The current Dave [DAVE] share price is $79.96. The Score for DAVE is 99, which is 98% above its historic median score of 50, and infers lower risk than normal.
- DAVE is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $41.04
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTGX is experiencing selling pressure, which indicates risk of future bearish movement.
DAVE Stock Price Chart
PTGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.52 | Sell |
| Relative Strength Index (14 RSI): | 31.27 | Sell |
| Chaikin Money Flow: | -545696 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.4 - 47.92) | Sell |
| Bollinger Bands (100): | (37.27 - 46.33) | Sell |
DAVE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.22 | Buy |
| Relative Strength Index (14 RSI): | 75.12 | Buy |
| Chaikin Money Flow: | -728941 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34.26 - 60.12) | Buy |
| Bollinger Bands (100): | (30.58 - 47.72) | Buy |
PTGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 45.09 | Sell |
| 20-day SMA: | 46.22 | Sell |
| 50-day SMA: | 45.54 | Sell |
| 200-day SMA: | 35.33 | Buy |
| 8-day EMA: | 44.31 | Sell |
| 20-day EMA: | 45.44 | Sell |
| 50-day EMA: | 44.68 | Sell |
| 200-day EMA: | 36.59 | Buy |
DAVE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 59.36 | Buy |
| 20-day SMA: | 47.79 | Buy |
| 50-day SMA: | 43.1 | Buy |
| 200-day SMA: | 37.56 | Buy |
| 8-day EMA: | 64.19 | Buy |
| 20-day EMA: | 52.82 | Buy |
| 50-day EMA: | 45.53 | Buy |
| 200-day EMA: | 36.06 | Buy |
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.45 per share, and a decrease next year of $3.95 per share.
Dave Earnings Growth & DAVE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.39 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.43 per share.
Protagonist Therapeutics Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Dave Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||